The Cigna Group (NYSE:CI) Shares Bought by Handelsbanken Fonder AB

Handelsbanken Fonder AB raised its holdings in The Cigna Group (NYSE:CI) by 3.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 80,145 shares of the health services provider’s stock after purchasing an additional 2,923 shares during the quarter. Handelsbanken Fonder AB’s holdings in The Cigna Group were worth $22,131,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Prospera Private Wealth LLC acquired a new position in The Cigna Group in the third quarter valued at $37,000. Collier Financial acquired a new position in shares of The Cigna Group during the fourth quarter worth about $32,000. ORG Wealth Partners LLC acquired a new position in shares of The Cigna Group during the fourth quarter worth about $34,000. Harbor Capital Advisors Inc. acquired a new position in shares of The Cigna Group during the third quarter worth about $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group during the fourth quarter worth about $37,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CI has been the topic of a number of recent analyst reports. Stephens dropped their price target on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a research note on Friday, January 31st. Wells Fargo & Company dropped their price target on shares of The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 4th. Raymond James reiterated a “strong-buy” rating and set a $360.00 price target (down from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. UBS Group dropped their price target on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Finally, Cantor Fitzgerald decreased their price objective on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $373.69.

The Cigna Group Stock Up 0.1 %

Shares of NYSE CI opened at $299.92 on Friday. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The company has a market capitalization of $83.42 billion, a PE ratio of 24.50, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The firm’s 50-day moving average is $286.35 and its two-hundred day moving average is $319.60.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the company posted $6.79 earnings per share. Equities analysts anticipate that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Wednesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio is 45.75%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.